Faulty Antibodies Continue to Enter US and European Markets, Warns Top ... GenomeWeb One year after alerting the proteomics community to a Chinese life sciences company that he said had infiltrated the US and European markets with faulty antibodies, researcher Nader Rifai told ProteoMonitor this week that the rogue firm is still at it. |
